The Effects of Hypoxia in Patients with Atrial Septal Defect (ASD) and Eisenmenger Syndrome: A Case Report
DOI:
https://doi.org/10.58344/ihj.v5i2.889Keywords:
atrial septal defect, Eisenmenger syndrome, hypoxia, pulmonary arterial hypertension, case reportAbstract
Background: Atrial septal defect (ASD) is a congenital heart disease characterized by an opening in the interatrial septum, allowing abnormal blood flow between the atria. In untreated cases, long-standing left-to-right shunting may progress to pulmonary arterial hypertension and eventually Eisenmenger syndrome, a severe condition associated with chronic hypoxemia, cyanosis, secondary erythrocytosis, and multiorgan complications. Case Presentation: A 46-year-old female patient was referred to Kudungga Regional Hospital with intermittent shortness of breath that worsened over four days, bluish discoloration of the fingers and toes, chest pain, palpitations, tremors, edema, and productive cough. Physical examination revealed cyanosis, clubbing fingers, periorbital edema, oxygen saturation of 74%, cardiomegaly, systolic murmur, and pulmonary rales. Supporting examinations showed biatrial enlargement and right ventricular dilation on electrocardiography, cardiomegaly and pulmonary hypertension on chest X-ray, elevated hemoglobin and hematocrit levels, thrombocytopenia, and severe pulmonary arterial hypertension on echocardiography. Echocardiography also revealed a secundum ASD with bidirectional shunt, right atrial and ventricular dilatation, right ventricular hypertrophy, severe tricuspid regurgitation, and preserved ejection fraction. The patient was diagnosed with secundum ASD bidirectional shunt, severe pulmonary arterial hypertension, Eisenmenger syndrome, bronchopneumonia, and hypoxia-induced tremor. Management included oxygen therapy, fluid restriction, diuretics, antibiotics, mucolytics, sildenafil, digoxin, antiplatelet therapy, and symptomatic treatment. After eight days of hospitalization, the patient showed clinical improvement and was discharged for outpatient follow-up. Conclusion: This case highlights the significant impact of hypoxia in ASD patients with Eisenmenger syndrome, particularly in causing cyanosis, secondary erythrocytosis, hyperviscosity symptoms, and neurological manifestations such as tremor.
References
Alamin, R. L., Raharjo, F. M., Gunawan, M., et al. (2024). Case report: Therapeutic approach to secondary polycythemia vera in an adult with Eisenmenger syndrome. Deka in Medicine, 1(3), e433.
Arvanitaki, A., Gatzoulis, M. A., Opotowsky, A. R., et al. (2022). Eisenmenger syndrome: JACC state-of-the-art review. Journal of the American College of Cardiology, 79(12).
Banerjee, R., & Opotowsky, A. R. (2024). Update on Eisenmenger syndrome: Review of pathophysiology and recent progress in risk assessment and management. International Journal of Cardiology Congenital Heart Disease, 17, 100520.
Brida, M., Chessa, M., Celermajer, D., et al. (2022). Atrial septal defect in adulthood: A new paradigm for congenital heart disease. European Heart Journal, 43(28), 2660–2671.
Destriyana, M., Martau, R. D., Darwis, I., et al. (2019). Suspek ventricular septal defect (VSD) dengan sindrom Eisenmenger pada dextrocardia situs inversus. Medula, 8(2), 132–136.
Diller, G. P., Lammers, A. E., & Oechslin, E. (2021). Treatment of adults with Eisenmenger syndrome: State of the art in the 21st century: A short overview. Cardiovascular Diagnosis and Therapy, 11(4), 1190–1199.
Elsaka, O., Noureldean, M., Gamil, M., et al. (2021). A review on Eisenmenger syndrome: Pathophysiology, investigations and treatment. Asian Journal of Research in Medical Sciences, 3(1), 98–112.
Forlemu, A. N., Ajmal, M., & Saririan, M. (2022). Atrial septal defect with Eisenmenger syndrome: A rare presentation. Case Reports in Cardiology, 2022, Article 8681761.
Gao, Y., Zhang, J., Tang, T., et al. (2024). Hypoxia pathways in Parkinson's disease: From pathogenesis to therapeutic targets. International Journal of Molecular Sciences, 25, 10484.
Garcia, A. C., Arachchillage, D. R., Kempny, A., et al. (2018). Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome. Heart, 104(1), 45–50.
Gurvitz, M., Krieger, E. V., Fuller, S., et al. (2025). 2025 ACC/AHA/HRS/ISACHD/SCAI guideline for the management of adults with congenital heart disease. Journal of the American College of Cardiology, 1, 1.
Jain, S., & Dalvi, B. (2018). Atrial septal defect with pulmonary hypertension: When/how can we consider closure? Journal of Thoracic Disease, 10(Suppl. 24), S2890–S2898.
Khan, M. S., Usman, M. S., Siddiqi, T. J., et al. (2018). Is anticoagulant beneficial in pulmonary arterial hypertension? A systematic review and meta-analysis. Circulation: Cardiovascular Quality and Outcomes, 11(9), 3004757.
Kumar, V., Abbas, A., & Aster, J. (2018). Buku ajar patologi dasar (10th ed.). Elsevier.
Malik, J., Ikram, U., Kamar, A., et al. (2020). Secundum atrial septal defect with early presentation of Eisenmenger syndrome and right-heart failure: A rare case report and literature review. Cureus, 12(7), e8980.
McKeown, D. J., Simmonds, M. J., & Kavanagh, J. J. (2019). Reduced blood oxygen levels induce changes in low-threshold motor unit firing that align with the individual's tolerance to hypoxia. Journal of Neurophysiology, 121, 1664–1671.
Nashat, H., Montanaro, C., Li, W., et al. (2018). Atrial septal defect and pulmonary arterial hypertension. Journal of Thoracic Disease, 10(Suppl. 24), S2953–S2965.
Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. (2021). Pedoman diagnosis dan tatalaksana hipertensi pulmonal. PERKI.
Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. (2022). Panduan tatalaksana penyakit jantung bawaan dewasa (PJBD). PERKI.
Pradhan, A., Vohra, S., Vishwakarma, P., et al. (2021). Medical therapy for Eisenmenger syndrome: A case report and review of literature. International Journal of Angiology, 30, 305–309.
Puteri, A. A., Oktaviono, Y. H., & Prasmono, A. (2022). Correlation between age and defect size with increased pulmonary arterial pressure in adult atrial septal defect (ASD) patients at cardiology and vascular medicine department Dr. Soetomo Public Hospital Surabaya 2019–2021. CCJ, 1, 15–21.
Rochmat, M. B., Hartopo, A. B., Setianto, B. Y., et al. (2024). Systolic blood pressure, cardiac index, and Eisenmenger syndrome are predictors of mortality in pulmonary arterial hypertension associated with congenital heart disease: An analysis from COHARD-PH Registry. Indonesian Journal of Cardiology, 45, 119–127.
Tarigan, P. A. (2025). Tinjauan farmakologis trihexyphenidyl dan penyalahgunaan di komunitas. Vitalitas Medis: Jurnal Kesehatan dan Kedokteran, 2(2), 20–26.
Yu, W., Song, X., Lin, C., et al. (2018). Interventions and mechanisms of N-acetylcysteine on monocrotaline-induced pulmonary arterial hypertension. Experimental and Therapeutic Medicine, 15, 5503–5509.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dyah Rachmasari, Elok Nurlisa Artiko

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.




